1. Home
  2. XERS vs AOSL Comparison

XERS vs AOSL Comparison

Compare XERS & AOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • AOSL
  • Stock Information
  • Founded
  • XERS 2005
  • AOSL 2000
  • Country
  • XERS United States
  • AOSL United States
  • Employees
  • XERS N/A
  • AOSL N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • AOSL Semiconductors
  • Sector
  • XERS Health Care
  • AOSL Technology
  • Exchange
  • XERS Nasdaq
  • AOSL Nasdaq
  • Market Cap
  • XERS 752.7M
  • AOSL 835.1M
  • IPO Year
  • XERS 2018
  • AOSL 2010
  • Fundamental
  • Price
  • XERS $5.49
  • AOSL $26.13
  • Analyst Decision
  • XERS Strong Buy
  • AOSL Strong Buy
  • Analyst Count
  • XERS 6
  • AOSL 3
  • Target Price
  • XERS $6.25
  • AOSL $30.67
  • AVG Volume (30 Days)
  • XERS 1.8M
  • AOSL 214.9K
  • Earning Date
  • XERS 08-07-2025
  • AOSL 08-06-2025
  • Dividend Yield
  • XERS N/A
  • AOSL N/A
  • EPS Growth
  • XERS N/A
  • AOSL N/A
  • EPS
  • XERS N/A
  • AOSL N/A
  • Revenue
  • XERS $222,551,000.00
  • AOSL $680,974,000.00
  • Revenue This Year
  • XERS $35.31
  • AOSL $7.05
  • Revenue Next Year
  • XERS $19.65
  • AOSL $2.54
  • P/E Ratio
  • XERS N/A
  • AOSL N/A
  • Revenue Growth
  • XERS 29.88
  • AOSL 3.57
  • 52 Week Low
  • XERS $2.10
  • AOSL $15.90
  • 52 Week High
  • XERS $6.07
  • AOSL $53.29
  • Technical
  • Relative Strength Index (RSI)
  • XERS 62.75
  • AOSL 47.17
  • Support Level
  • XERS $4.94
  • AOSL $24.01
  • Resistance Level
  • XERS $5.22
  • AOSL $28.85
  • Average True Range (ATR)
  • XERS 0.22
  • AOSL 1.25
  • MACD
  • XERS -0.01
  • AOSL -0.45
  • Stochastic Oscillator
  • XERS 86.44
  • AOSL 35.04

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

Share on Social Networks: